Company Filing History:
Years Active: 2019-2023
Title: Paul Robbins: Innovator in Cancer Treatment
Introduction
Paul Robbins is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cancer treatment, particularly through his innovative patents. With a total of 5 patents, Robbins has focused on developing therapies that target specific cancer markers.
Latest Patents
Among his latest patents, Robbins has developed Anti-B7-H1 antibodies for treating tumors. This patent outlines methods for treating B7-H1-expressing tumors by administering an effective amount of MEDI4736 or an antigen-binding fragment thereof. Another significant patent involves Anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer. This invention provides methods for treating non-small cell lung cancers by administering MEDI4736 or an antigen-binding fragment thereof, along with tremelimumab or an antigen-binding fragment thereof.
Career Highlights
Robbins is currently associated with MedImmune Limited, where he continues to work on groundbreaking cancer therapies. His research and inventions have the potential to change the landscape of cancer treatment, offering new hope to patients.
Collaborations
Robbins has collaborated with notable colleagues, including Rajesh Narwal and David Fairman. These partnerships have contributed to the advancement of his research and the development of innovative treatments.
Conclusion
Paul Robbins stands out as a dedicated inventor in the field of cancer treatment, with a focus on innovative therapies that target specific cancer markers. His work continues to inspire advancements in medical science and offers hope for improved patient outcomes.